Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Masao, Fukunaga"'
Autor:
Yutaka Ohsawa, Hideaki Ohtsubo, Asami Munekane, Kohei Ohkubo, Tatsufumi Murakami, Masahiro Fujino, Shin-ichiro Nishimatsu, Hiroki Hagiwara, Hirotake Nishimura, Ryuki Kaneko, Takahiro Suzuki, Ryuichi Tatsumi, Wataru Mizunoya, Atsushi Hinohara, Masao Fukunaga, Yoshihide Sunada
Publikováno v:
The American Journal of Pathology. 193:591-607
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::952a4e5707f305e39c85ee727c16e580
https://doi.org/10.1016/j.ajpath.2023.01.009
https://doi.org/10.1016/j.ajpath.2023.01.009
Autor:
Teruki Sone, Naohiro Kon, Kenneth W. Gaither, Naoki Okubo, Taisuke Osakabe, Yutaka Nakayama, Masao Fukunaga, Masako Ito, Toshitaka Nakamura
Publikováno v:
Bone Reports, Vol 7, Iss C, Pp 164-171 (2017)
Denosumab, a human monoclonal antibody against RANK ligand, is shown to have strong anti-fracture effects in Japanese osteoporosis patients. However, there have been no data showing actions on Japanese bone architecture. Here we show that denosumab c
Externí odkaz:
https://doaj.org/article/14e0114990354188a2a5ada90789726e
Autor:
S. Fujiwara, Masao Fukunaga, Osamu Chaki, Masaaki Inaba, Yasuo Imanishi, Junichi Takada, Noriko Yoshimura, Shoichi Ichimura, Takami Miki, Hiroshi Hagino, Masataka Shiraki, Yoshiki Nishizawa, Masakazu Miura, Hiroaki Ohta
Publikováno v:
Clinica Chimica Acta. 498:101-107
With the aging of society, the number of osteoporosis-related fractures is increasing. Prevention of osteoporosis and maintenance of the quality of life of osteoporosis patients require early diagnosis, effective treatment, and highly precise treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70210f4272090f9948e689cf299fab6b
https://doi.org/10.1016/j.cca.2019.08.012
https://doi.org/10.1016/j.cca.2019.08.012
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107953 (2014)
Substantial evidence from animal studies indicates that jumping increases bone mass and strength. However, most studies have focused on the take-off, rather than the landing phase of jumps. Thus, we compared the effects of landing and upward jump imp
Externí odkaz:
https://doaj.org/article/3ce7dd2c7b5f435d85b1881e628c0133
Autor:
Yukari Uemura, Toshitaka Nakamura, Masataka Shiraki, Eiji Itoi, Masao Fukunaga, Hiroaki Ohta, Hajime Orimo
Publikováno v:
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association. 26(6)
Backgroud Changes in bone mineral density (BMD) are a potential surrogate marker for fracture endpoints in clinical trials. However little is known whether the increase in BMD in response to combination treatment with alendronate plus alfacalcidol is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10a1c0d3540645490b97495580d4da69
https://pubmed.ncbi.nlm.nih.gov/33358235
https://pubmed.ncbi.nlm.nih.gov/33358235
Autor:
Mayumi Tsukiyama, Hiroaki Ohta, Akira Taguchi, Teruhiko Miyazaki, Masao Fukunaga, Toshitaka Nakamura, Hiroshi Hagino, Hajime Orimo, Masataka Shiraki, Satoshi Mori, Satoshi Soen, Shiro Tanaka, Yukari Uemura, Toshitsugu Sugimoto, Teruki Sone
We conducted a head-to-head randomized trial of minodronate, a bisphosphonate, and raloxifene, a selective estrogen receptor modulator, to obtain clinical evidence and information about their efficacy and safety. The Japanese Osteoporosis Interventio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22a6bc9e5cc9981e9e75e989fe85f017
Autor:
Takami Miki, Masao Fukunaga, Hiroshi Hagino, Shinobu Akachi, Tetsuo Nakano, Masako Ito, Toshitaka Nakamura, Yoshiki Nishizawa, Toshitsugu Sugimoto, Hideaki Kishimoto, Teruki Sone, Masataka Shiraki
Publikováno v:
Current Medical Research and Opinion. 35:447-454
Very few reports have described changes in bone mineral density (BMD) with long-term, once weekly administration of elcatonin, and its effects in reducing incident fractures remain unverified. Therefore, the efficacy and safety of once weekly elcaton
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eef0efcdd23315fda7d1d257f18207f0
https://doi.org/10.1080/03007995.2018.1498780
https://doi.org/10.1080/03007995.2018.1498780
Autor:
Masao Fukunaga
Publikováno v:
Joho Chishiki Gakkaishi. 26:331-336
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5bd46e2d32d33282dec1a41146ffd44
https://doi.org/10.2964/jsik_2017_006
https://doi.org/10.2964/jsik_2017_006
Autor:
Eiji Itoi, Yasuo Ohashi, Hajime Orimo, Itsuo Gorai, Satoshi Mori, Toshitaka Nakamura, Hiroaki Ohta, Masataka Shiraki, Nobuaki Miyakawa, Masao Fukunaga, Toshitsugu Sugimoto, Yukari Uemura, Hiroshi Hagino, Shiro Tanaka, Takayuki Hosoi, Teruhiko Miyazaki
Publikováno v:
Journal of Bone and Mineral Metabolism. 35:385-395
The aim of this study was to investigate the efficacy of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis and to explore subsets of patients for which concurrent treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c0981a44940f764ed5b66f6cba9c2a9
https://doi.org/10.1007/s00774-016-0768-5
https://doi.org/10.1007/s00774-016-0768-5
Autor:
Masao Fukunaga
Publikováno v:
Joho Chishiki Gakkaishi. 26:136-141
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdf5f94ff74e389dca981bac4d957de1
https://doi.org/10.2964/jsik_2016_011
https://doi.org/10.2964/jsik_2016_011